Ex-Rep Says Forest Labs Pushed Off-Label Use Of Namenda
Forest Laboratories Inc. has been hit with a False Claims Act suit by a former sales representative claiming the pharmaceutical giant regularly markets Namenda to treat mild Alzheimer's disease, an off-label...To view the full article, register now.
Already a subscriber? Click here to view full article